Anatoly G. Antoshechkin
United States of America
conducts basic research at Nulab on the effects of nutrients on human health. Dr. Antoshechkin developed the Admax® adaptogenic ingredient, which has been the subject of three clinical trials, including a full gene expression analysis. He graduated as a medical doctor from the First Moscow Medical Institute and also holds a doctorate in Molecular Genetics. Dr. Antoshechkin previously worked at the Soviet Institute of Space Research, the Russian Institute of Molecular Genetics and as a scientific consultant to the Russian Olympic Committee. He is a member of the New York Academy of Sciences
ANATOLY Research in effects of nutrients on human health.